Yahoo Web Search

Search results

    • Telix Pharmaceuticals (OTCMKTS:TLPPF) Shares Up 0.8%

      ETF DAILY NEWS· 23 hours ago

      ...brain cancer); TLX66-CDx to treat bone marrow conditioning and rare diseases; TLX300-CDx for the treatment and diagnosis of soft tissue sarcoma; TLX250, which is in Phase II clinical trials for the diagnosis and treatment of kidney cancer; TLX591, which is in Phase III clinical trials for the...